0001213900-19-001167.txt : 20190124
0001213900-19-001167.hdr.sgml : 20190124
20190124165127
ACCESSION NUMBER: 0001213900-19-001167
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
EFFECTIVENESS DATE: 20190124
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Can-Fite BioPharma Ltd.
CENTRAL INDEX KEY: 0001536196
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-331328
FILM NUMBER: 19540448
BUSINESS ADDRESS:
STREET 1: 10 BAREKET STREET, KIRYAT MATALON
STREET 2: P.O. BOX 7537
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951778
BUSINESS PHONE: 972 39241114
MAIL ADDRESS:
STREET 1: 10 BAREKET STREET, KIRYAT MATALON
STREET 2: P.O. BOX 7537
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951778
D
1
primary_doc.xml
X0708
D
LIVE
0001536196
Can-Fite BioPharma Ltd.
10 BAREKET STREET, KIRYAT MATALON
PETACH TIKVA
L3
ISRAEL
4951778
972 39241114
ISRAEL
None
None
Corporation
true
Ilan
Cohn
10 Bareket Street, Kiryat Matalon
PO Box 7537
Petach Tikva
L3
ISRAEL
4951778
Director
Pnina
Fishman
10 Bareket Street, Kiryat Matalon
PO Box 7537
Petach Tikva
L3
ISRAEL
4951778
Executive Officer
Director
Motti
Farbstein
10 Bareket Street, Kiryat Matalon
PO Box 7537
Petach Tikva
L3
ISRAEL
4951778
Executive Officer
Director
Guy
Regev
10 Bareket Street, Kiryat Matalon
PO Box 7537
Petach Tikva
L3
ISRAEL
4951778
Director
Abraham
Sartini
10 Bareket Street, Kiryat Matalon
PO Box 7537
Petach Tikva
L3
ISRAEL
4951778
Director
Israel
Shamay
10 Bareket Street, Kiryat Matalon
PO Box 7537
Petach Tikva
L3
ISRAEL
4951778
Director
Yaacov
Goldman
10 Bareket Street, Kiryat Matalon
PO Box 7537
Petach Tikva
L3
ISRAEL
4951778
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2019-01-18
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE
4TH FLOOR
NEW YORK
NY
NEW YORK
10022
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
false
2350000
2350000
0
The warrants and shares underlying the warrants, the subject matter of this Form D were issued in connection with an offering of (i) 2,238,096 ADSs issued in a registered direct offering, and (ii) unregistered warrants to purchase 2,238,096 ADSs.
false
1
141000
0
H.C. Wainwright is also entitled to non-accountable expense reimbursement of $50,000 and warrants to purchase an aggregate of 111,905 ADSs exercisable at $1.30 per ADS for five years.
0
Issuer expects to use proceeds from the offering for working capital purposes which includes payment of salaries to the named executive officers
false
Can-Fite BioPharma Ltd.
/s/ Motti Farbstein
Motti Farbstein
Chief Operating and Financial Officer
2019-01-24